There are a number of nonopioid options, as well as nondrug options, for pain management, explained Jeff White, PharmD, MS, staff vice president, Anthem.
There are a number of nonopioid options, as well as nondrug options, for pain management, explained Jeff White, PharmD, MS, staff vice president, Anthem.
Transcript
What are some available nonopioid options to pain management?
There are a number of nonopioid options to pain management. It’s important to start with the evidence to understand the true clinical benefits and harms of therapy, and that will guide the alternatives. There’s a substantial amount of evidence to support nonopioid therapies. For example, there are the NSAIDS [nonsteroidal anti-inflammatory drugs], such as Motrin or Naprosyn. There are also antidepressants, there are also anticonvulsants such as gabapentin, and there’s other topical therapies, and many others to help treat pain.
It’s important to guide the therapy towards the type of pain for which there’s evidence to support use for that particular condition. There’s also a number of nondrug-related options to address and manage pain. For example, there’s physical therapy, there’s exercise and stretching, acupuncture, yoga, and a number of other evidence-based nondrug alternatives.
Are there any misconceptions about these alternatives?
A common misconception is that pain needs to be treated with an opioid when there’s limited evidence on the long-term safety and efficacy of opioid therapy. Whereas the nonopioid alternatives, there’s strong evidence to support long-term safety and efficacy of those drugs.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More